CONSYNANCE THERAPEUTICS

ConSynance Therapeutics is a clinical-stage drug development company based in Rensselaer, New York. ConSynance’s pipeline includes innovative treatments for non-alcoholic steatohepatitis (NASH), the orphan disease Prader-Willi Syndrome (PWS), and irritable bowel syndrome (IBS). They believe that these assets have major competitive advantage over existing or in-development agents. These investigational therapeutics are the output of several years of previous drug discovery efforts at Albany Molecular Research, Inc (AMRI). The founders of ConSynance Therapeutics, Inc. were on the leadership team at AMRI during this effort and have licensed these assets into ConSynance as a vehicle for accelerating their development.

#SimilarOrganizations #People #Website #More

CONSYNANCE THERAPEUTICS

Social Links:

Linkedin

Industry:

Biotechnology Therapeutics

Founded:

2015-01-01

Address:

Rensselaer, New York, United States

Country:

United States

Website Url:

http://www.consynance.com

Total Employee:

1+

Status:

Active

Contact:

518-275-0176

Email Addresses:

[email protected]

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Euro Microsoft Exchange Online Office 365 Mail

Similar Organizations

context-therapeutics-logo

Context Therapeutics

Context Therapeutics is a clinical-stage biopharmaceutical company.

Current Employees Featured

john-maki_image

John Maki
John Maki President @ ConSynance Therapeutics
President
2019-04-01

shuang-liu_image

Shuang Liu
Shuang Liu CEO @ ConSynance Therapeutics
CEO
2019-07-01

Founder

peter-guzzo_image

Peter Guzzo

shuang-liu_image

Shuang Liu

Official Site Inspections

http://www.consynance.com

Host Informations
Whois Informations

Loading ...

More informations about "ConSynance Therapeutics" on Search Engine